TNF and nephrosis: In addition, her recent therapy with Adalimumab also raised concern for possible drug-induced lupus-like nephritis, based on prior case reports that associated the anti-TNF therapies with the development of proliferative lupus nephritis during treatment for Rheumatoid Arthritis.[3] In the current case, in contrast to those cases of Adalimumab drug-induced lupus-like nephritis reported in the literature, the worsening of nephrosis occurred after discontinuation of the drug.